Related Experiment Video
Updated: Jul 6, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Targeted long-read sequencing with adaptive sampling enables the integrated genomic and epigenomic profiling of
Federico Rondot1,2, Federica Centofanti3, Anna Micaletto4
1Department of Public Health and Pediatrics, University of Turin, 10126, Turin, Italy.
Abstract:
Conventional molecular diagnostics for imprinting disorders rely on sequential DNA-intensive assays, which are expensive, time-consuming, and often insufficient for detecting mosaicism, resulting in suboptimal clinical management. Here, we present a targeted long-read sequencing strategy that enables the integrated detection of DNA methylation, copy-number variants, and sequence variants in a single assay for Beckwith-Wiedemann spectrum (BWSp), a genomic imprinting disorder caused by genetic or epigenetic alterations affecting imprinting control regions 1 and 2 (IC1/IC2) within the 11p15.5 locus. We evaluated three Oxford Nanopore Technologies (ONT) workflows: adaptive sampling on MinION (AS-MinION), adaptive sampling on PromethION P2 (AS-P2), and whole-genome sequencing on P2 (WGS-P2). Three cases of BWSp patients were analyzed, including two with mosaic paternal uniparental disomy (pUPD) and one with IC2 loss of methylation (LoM). We compared sequencing output, genome-wide and region-of-interest coverage, IC1/IC2 methylation profiles, and variant concordance with Illumina short read sequencing using the Simplex basecalling model. AS-P2 achieved the highest coverage of target regions while maintaining broad and uniform genome-wide coverage, outperforming AS-MinION and WGS-P2. This dual performance enables efficient and scalable simultaneous genetic and epigenetic analysis in a single sequencing run. Using Simplex basecalling, AS-P2 accurately identified all underlying molecular defects in conventionally characterized samples. In conclusion, AS-P2 enablesa cost-effective and sensitive approach for the molecular diagnosis of imprinting disorders, particularly in cases with mosaic or complex genetic and epigenetic architectures.

